Cargando…
Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders
Neuromuscular disorders (NMDs) comprise a heterogeneous group of disorders that affect about one in every thousand individuals worldwide. The vast majority of NMDs has a genetic cause, with about 600 genes already identified. Application of genetic testing in NMDs can be useful for several reasons:...
Autores principales: | Barp, Andrea, Mosca, Lorena, Sansone, Valeria Ada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070835/ https://www.ncbi.nlm.nih.gov/pubmed/33919863 http://dx.doi.org/10.3390/diagnostics11040701 |
Ejemplares similares
-
Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New
por: Barp, Andrea, et al.
Publicado: (2021) -
Anti-HMGCR myopathy misdiagnosed as motor neuron disease and complicated with COVID-19 infection
por: Barp, Andrea, et al.
Publicado: (2021) -
Genetics of Neuromuscular Disorders
por: Seashore, Margretta R.
Publicado: (1990) -
Role of Radiologic Imaging in Genetic and Acquired Neuromuscular Disorders
por: Ortolan, Paolo, et al.
Publicado: (2015) -
Hurdles to Cardioprotection in the Critically Ill
por: See Hoe, Louise E, et al.
Publicado: (2019)